ClinicalTrials.Veeva

Menu

Autofluorescence-guided Hemithyroidectomy in a Low-volume, Non-parathyroid Insitution: A Randomized Clinical Trial

R

Regional Hospital West Jutland

Status

Completed

Conditions

Autotransplantation
Autofluorescence
Thyroidectomy

Treatments

Device: Fluobeam LX
Other: Conventional surgery without NIRAF assistance

Study type

Interventional

Funder types

Other

Identifiers

NCT05044351
Autofluorescence2.0

Details and patient eligibility

About

Parathyroid damage and inadvertent excision unfortunately happens frequently in thyroid surgery. The use of near-infrared autofluorescence (NIRAF) intraoperatively, seems to be helpful in terms of parathyroid identification and preservation.

In order to cover every aspect of the impact of NIRAF in thyroid surgery, an evaluation in low-volume, non-parathyroid centers is needed:

Aim: To investigate the impact of NIRAF on hemithyroidectomy by evaluating parathyroid identification, damage and the rate of inadvertent parathyroid excision in a low-volume, non-parathyroid institution.

Full description

Patients referred for hemithyroidectomy will be randomized to either:

(A) NIRAF-assisted hemithyroidectomy (Fluobeam LX) or (B) Conventional hemithyroidectomy. PTH and ionized calcium will assessed preoperatively, on postoperative day 1 (POD1) and one month following surgery. Parathyroid identification rates, rates of autoimplantation and inadvertently excised parathyroid glands will be assessed and compared.

Enrollment

170 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients referred for thyroid lobectomy
  • Age > 18
  • Able to understand patient information
  • Able to give informed consent

Exclusion criteria

  • Completion lobectomy
  • Need for accelerated surgery
  • Age < 18
  • Unable to understand patient information
  • Unable to give informed consent

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

170 participants in 2 patient groups

(A): NIRAF-assisted surgery
Experimental group
Description:
Patients undergoing NIRAF-assisted hemithyroidectomy
Treatment:
Device: Fluobeam LX
(B): Conventional surgery
Active Comparator group
Description:
Patients undergoing conventional hemithyroidectomy without NIRAF-assistance
Treatment:
Other: Conventional surgery without NIRAF assistance

Trial contacts and locations

1

Loading...

Central trial contact

Ali Abood, MD; Therese Ovesen, MD, DMSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems